查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2080371

造影劑市場：2026-2032年全球市場預測（依產品類型、影像方法、劑型、給藥途徑、應用及最終用戶分類）

Contrast Media Market by Product Type, Imaging Modality, Form, Route of Administration, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，造影劑市場規模將達到 123.5 億美元，複合年成長率為 8.26%。

主要市場統計數據
基準年 2025 70.8億美元
預計年份：2026年 76.4億美元
預測年份 2032 123.5億美元
複合年成長率 (%) 8.26%

造影劑市場執行摘要

造影劑在現代CT、MRI、超音波、透視和介入放射學等影像檢查中至關重要，能夠提高血管、器官、軟組織和胃腸道結構的顯影效果。全球心血管疾病、癌症、神經系統疾病、創傷和後續觀察慢性腎臟病等疾病負擔的加重，推動了造影劑需求的成長。高品質的影像對於所有這些疾病的診斷、治療方案製定和後續追蹤都至關重要。

造影劑市場的變革性變化

造影劑市場趨勢正從主要關注增加使用量轉向優先考慮準確性、安全性和工作流程效率。在放射學領域，我們遵循美國放射學會 (ACR) 和歐洲泌尿生殖放射學會 (ESUR) 等機構的指南，在臨床適用的情況下優先使用低滲透壓和等滲碘基造影劑、大環釓基造影劑以及超音波造影劑。

人工智慧（AI）的累積影響

人工智慧 (AI) 正在對整個造影劑價值鏈產生累積影響。在臨床影像領域，AI 驅動的重建、分割、工作流程最佳化和方案選擇能夠幫助放射科團隊在保持影像品質的同時，減少造影劑用量、重複檢查次數和檢查時間。 AI 工具還能透過辨識腎功能損傷、先前過敏史、藥物交互作用和重複影像檢查暴露等風險因素，輔助患者分層。

關於造影劑的關鍵區域見解

亞太地區（包括中國、印度、日本、韓國、澳洲和東南亞）人口大規模，醫院基礎設施不斷完善，CT和MRI等影像檢查設備普及率不斷提高，以及影像引導療法的應用日益廣泛，因此成為影像診斷需求的主要驅動力。根據聯合國人口數據，該地區居住著全球相當大比例的人口，而癌症、心血管疾病、糖尿病、腎臟病和老齡化相關疾病發病率的上升，正在對影像檢查產生結構性需求。

經濟和政策集團的關鍵小組見解

東南亞國協的需求主要受都市化、醫療旅遊、非傳染性疾病篩檢以及公共部門對三級醫療保健的投資所驅動，尤其是在新加坡、泰國、馬來西亞、印尼、越南和菲律賓。海灣合作理事會國家正透過國家轉型計畫、專科醫院和複雜的三級醫療保健體系，不斷擴展先進的影像技術，從而導致對高可靠性造影劑輸送、輸注系統和方案管理的需求日益成長。

主要國家對造影劑需求的見解

美國擁有極高的CT和MRI使用率、先進的介入放射學技術、FDA批准的創新技術、活躍的腫瘤影像學以及廣泛應用的自動造影輸液設備，因此蘊藏著巨大的發展機會。加拿大在其省級醫療保健系統中優先考慮安全性、採購效率和公平獲取，而墨西哥和巴西則在私立醫院網路、先進的診斷中心和大都會圈不斷擴大影像檢查的覆蓋範圍。

為行業領導者提供的實用建議

產業領導者應優先考慮實證安全性、供應穩定性以及符合規範的價值，而非僅依賴價格競爭。製造商可以透過以下方式增強自身差異化優勢：大環磁振造影、低滲透壓和等滲碘基造影劑產品組合、微氣泡超音波應用、腎臟風險管理支援以及可減少廢棄物並支持造影劑自動化管理的包裝。

調查方法

本執行摘要採用系統性的一手和二手研究方法編寫，遵循市場情報的最佳實踐。研究資料包括監管資料庫、臨床指南、同行評審的放射學文獻、公共衛生統計數據、醫院採購指標、產品核可資訊、藥物安全監測最新進展、供應鏈趨勢以及來自醫學和診斷影像領域相關人員的專家意見。

結論

造影劑市場正邁入一個更規範、技術驅動的階段，安全性、可近性和工作流程效率是關鍵的競爭優勢。診斷影像檢查的日益普及、人口老化、癌症和心血管疾病負擔的加重、人們對腎臟風險認知的不斷提高以及介入手術的擴展，都持續支撐著造影劑市場強大的臨床意義。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：造影劑市場：依產品類型分類

  • 鋇基造影劑
  • 钆基造影劑
  • 碘基造影劑
  • 微氣泡造影劑

第8章造影劑市場：依診斷影像方法分類

  • 電腦斷層掃描（CT）
  • 磁振造影（MRI）
  • 光學成像
  • 超音波
  • X光和透視

第9章：造影劑市場：以劑型分類

  • 液體
  • 貼上
  • 粉末

第10章：造影劑市場：依給藥途徑分類

  • 血管內給藥途徑
  • 口服
  • 直腸給藥

第11章：造影劑市場：依應用領域分類

  • 癌症
  • 心血管疾病
  • 消化系統疾病
  • 肌肉骨骼疾病
  • 腎臟疾病
  • 神經病變

第12章造影劑市場：依最終用戶分類

  • 門診手術中心
  • 診斷影像中心
  • 醫院

第13章：造影市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章造影劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章造影

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Acro Lifesciences（I）Pvt. Ltd.
  • APOLLO RT Co. Ltd.
  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Spa
  • Daiichi Sankyo Co. Ltd.
  • Eskay Iodine Pvt. Ltd.
  • Fuji Pharma Co. Ltd.
  • GE Healthcare
  • Guerbet SA
  • JB Chemicals & Pharmaceuticals Limited
  • Jodas Expoim Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • Livealth Biopharma
  • M.Biotech Limited
  • Maya Biotech
  • MEDTRON AG
  • nanoPET Pharma GmbH
  • Novalek Pharmaceuticals Pvt Ltd.
  • Rege Imaging & Cine Films（P）Ltd.
  • SANOCHEMIA Pharmazeutika GmbH
  • Spago Nanomedical AB
  • Trivitron Healthcare
  • ulrich GmbH & Co. KG
  • Unijules Life Sciences Limited
  • Vitalquan, LLC
  • Zhejiang Starry Pharmaceutical Co., Ltd.
Product Code: MRR-434CCDA04E9E

The Contrast Media Market is projected to grow by USD 12.35 billion at a CAGR of 8.26% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.08 billion
Estimated Year [2026] USD 7.64 billion
Forecast Year [2032] USD 12.35 billion
CAGR (%) 8.26%

Contrast Media Market Executive Summary

Contrast media are indispensable to modern diagnostic imaging, improving the visibility of blood vessels, organs, soft tissues, and gastrointestinal structures across CT, MRI, ultrasound, fluoroscopy, and interventional radiology. Demand is supported by the documented global burden of cardiovascular disease, cancer, neurological disorders, trauma, and chronic kidney disease, all of which rely on high-quality imaging for diagnosis, treatment planning, and follow-up.

The contrast media landscape is shaped by four core product families: iodinated contrast media for CT and angiography, gadolinium-based contrast agents for MRI, microbubble agents for contrast-enhanced ultrasound, and barium-based agents for gastrointestinal studies. Adoption is increasingly linked to safer formulations, automated injectors, protocol standardization, and imaging workflows that reduce dose, waste, and adverse-event risk while preserving diagnostic confidence.

Transformative Shifts in the Contrast Media Landscape

The contrast media landscape is shifting from volume-driven use toward precision, safety, and workflow efficiency. Radiology departments are prioritizing low-osmolar and iso-osmolar iodinated agents, macrocyclic gadolinium agents, and ultrasound contrast where clinically appropriate, reflecting guidance from organizations such as the American College of Radiology and the European Society of Urogenital Radiology.

Healthcare systems are also moving toward protocol-based procurement, centralized contrast management, and integrated injector platforms. Hospitals are responding to documented supply-chain disruptions by diversifying qualified suppliers, building inventory resilience, monitoring expiration risk, and using dose optimization to protect access during shortages without compromising diagnostic quality.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across the contrast media value chain. In clinical imaging, AI-enabled reconstruction, segmentation, workflow orchestration, and protocol selection can help radiology teams maintain image quality while reducing contrast dose, repeat scans, and scan time. AI tools also support patient stratification by identifying risk factors such as impaired renal function, prior hypersensitivity reactions, medication interactions, and repeat imaging exposure.

For manufacturers and providers, AI improves demand planning, inventory control, adverse-event monitoring, injector utilization analytics, and post-market signal detection. Adoption must remain aligned with FDA and EU software-as-a-medical-device expectations, cybersecurity controls, data governance, and validated clinical evidence to prevent bias and protect patient safety.

Key Regional Insights for Contrast Media

Asia-Pacific is a major demand engine because it combines large population scale, expanding hospital infrastructure, rising CT and MRI access, and growing use of image-guided care across China, India, Japan, South Korea, Australia, and Southeast Asia. UN population data confirms that the region contains the majority of the global population, creating structural need for diagnostic imaging as cancer, cardiovascular disease, diabetes, renal disease, and age-related disorders increase.

North America remains a high-value environment due to advanced radiology networks, FDA-regulated product innovation, broad CT and MRI utilization, and strong adoption of interventional radiology. Europe is shaped by EMA oversight, the EU Medical Device Regulation, ESUR safety guidance, pharmacovigilance discipline, and healthcare sustainability expectations. Latin America is expanding access through public and private hospital investment, especially in urban diagnostic centers, while the Middle East is accelerating imaging modernization through national health strategies and specialty care investments. Africa shows long-term potential as countries improve diagnostic capacity, although WHO and IAEA assessments continue to highlight uneven access to advanced imaging equipment, radiologists, technologists, and reliable medical supply chains.

Key Group Insights Across Economic and Policy Blocs

ASEAN demand is supported by urbanization, medical tourism, noncommunicable disease screening, and public investment in tertiary hospitals, particularly across Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is advancing premium diagnostic imaging capacity through national transformation programs, specialized hospitals, and complex tertiary care pathways, reinforcing demand for high-reliability contrast supply, injector systems, and protocol governance.

The European Union emphasizes clinical safety, pharmacovigilance, sustainability, regulatory compliance, and cross-border evidence standards, making evidence-based product differentiation essential. BRICS markets combine large patient pools with expanding hospital infrastructure, local manufacturing ambitions, and cost-sensitive procurement. G7 countries lead in premium imaging, clinical guideline adoption, digital radiology infrastructure, and AI-enabled workflow development. NATO markets benefit from mature hospital systems, emergency preparedness, and defense-related trauma readiness, where rapid vascular assessment, CT angiography, and interventional imaging remain clinically important.

Key Country Insights for Contrast Media Demand

The United States is a leading value opportunity due to high CT and MRI utilization, advanced interventional radiology, FDA-cleared innovation, oncology imaging intensity, and widespread use of automated contrast injectors. Canada emphasizes safety, procurement efficiency, and equitable access across provincial health systems, while Mexico and Brazil are expanding private hospital networks, advanced diagnostic centers, and imaging access in large metropolitan areas.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show strong demand tied to oncology, cardiovascular imaging, emergency care, and aging populations, while Russia maintains demand through large hospital systems despite supply-chain complexity. China and India are scale-driven opportunities as imaging capacity expands and chronic disease diagnosis increases. Japan and South Korea lead in advanced modalities, quality standards, and high-throughput radiology operations, while Australia combines strong clinical governance with broad access to modern radiology services and structured safety protocols.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-backed safety, supply resilience, and protocol-level value rather than competing solely on price. Manufacturers can strengthen differentiation through macrocyclic MRI agents, low-osmolar and iso-osmolar iodine portfolios, microbubble ultrasound applications, renal-risk management support, and packaging that reduces waste and supports automated contrast management.

Providers should standardize contrast protocols, integrate renal-risk screening, document allergy and hypersensitivity history, train staff on extravasation and emergency response, and use injector analytics to optimize dose and reduce waste. Commercial teams should align with hospital procurement goals by documenting total cost of ownership, availability performance, clinical education, product traceability, and compliance with ACR, ESUR, FDA, EMA, and local pharmacovigilance requirements.

Research Methodology

This executive summary is developed using a structured secondary and primary research approach consistent with market intelligence best practices. Inputs include regulatory databases, clinical guidelines, peer-reviewed radiology literature, public health statistics, hospital procurement indicators, product approvals, pharmacovigilance updates, supply-chain observations, and expert perspectives from healthcare and imaging stakeholders.

Findings are triangulated across demand drivers, modality trends, regional healthcare investment, clinical safety considerations, competitive positioning, and expert validation. The methodology emphasizes data integrity, source verification, and practical market interpretation so stakeholders can evaluate contrast media opportunities by product class, imaging modality, end user, region, group, and country while avoiding unsupported sizing or forecasting claims.

Conclusion

The contrast media market is moving into a more disciplined, technology-enabled phase where safety, access, and workflow efficiency define competitive advantage. Rising diagnostic imaging use, aging populations, cancer and cardiovascular disease burden, renal-risk awareness, and expanding interventional procedures continue to support durable clinical relevance.

Future leadership will depend on resilient supply chains, clinically differentiated formulations, AI-enabled imaging operations, and compliance with evolving regulatory, pharmacovigilance, and sustainability expectations. Organizations that combine product reliability with clinical education, digital workflow support, and regional adaptation are best positioned to strengthen performance in contrast-enhanced imaging.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Contrast Media Market, by Product Type

  • 7.1. Barium-based Contrast Media
  • 7.2. Gadolinium-based Contrast Media
  • 7.3. Iodinated Contrast Media
  • 7.4. Microbubble Contrast Media

8. Contrast Media Market, by Imaging Modality

  • 8.1. Computed Tomography (CT)
  • 8.2. Magnetic Resonance Imaging (MRI)
  • 8.3. Optical Imaging
  • 8.4. Ultrasound
  • 8.5. X-Ray & Fluoroscopy

9. Contrast Media Market, by Form

  • 9.1. Liquid
  • 9.2. Paste
  • 9.3. Powder

10. Contrast Media Market, by Route of Administration

  • 10.1. Intravascular Route
  • 10.2. Oral Route
  • 10.3. Rectal Route

11. Contrast Media Market, by Application

  • 11.1. Cancer
  • 11.2. Cardiovascular Diseases
  • 11.3. Gastrointestinal Disorders
  • 11.4. Musculoskeletal Disorders
  • 11.5. Nephrological Disorders
  • 11.6. Neurological Disorders

12. Contrast Media Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Diagnostic Imaging Centers
  • 12.3. Hospitals

13. Contrast Media Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Contrast Media Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Contrast Media Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Acro Lifesciences (I) Pvt. Ltd.
  • 17.2. APOLLO RT Co. Ltd.
  • 17.3. Bayer AG
  • 17.4. Beijing Beilu Pharmaceutical Co., Ltd.
  • 17.5. Bracco Spa
  • 17.6. Daiichi Sankyo Co. Ltd.
  • 17.7. Eskay Iodine Pvt. Ltd.
  • 17.8. Fuji Pharma Co. Ltd.
  • 17.9. GE Healthcare
  • 17.10. Guerbet SA
  • 17.11. J. B. Chemicals & Pharmaceuticals Limited
  • 17.12. Jodas Expoim Pvt. Ltd.
  • 17.13. Lantheus Medical Imaging, Inc.
  • 17.14. Livealth Biopharma
  • 17.15. M.Biotech Limited
  • 17.16. Maya Biotech
  • 17.17. MEDTRON AG
  • 17.18. nanoPET Pharma GmbH
  • 17.19. Novalek Pharmaceuticals Pvt Ltd.
  • 17.20. Rege Imaging & Cine Films (P) Ltd.
  • 17.21. SANOCHEMIA Pharmazeutika GmbH
  • 17.22. Spago Nanomedical AB
  • 17.23. Trivitron Healthcare
  • 17.24. ulrich GmbH & Co. KG
  • 17.25. Unijules Life Sciences Limited
  • 17.26. Vitalquan, LLC
  • 17.27. Zhejiang Starry Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTRAST MEDIA MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CONTRAST MEDIA MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CONTRAST MEDIA MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CONTRAST MEDIA MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BARIUM-BASED CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BARIUM-BASED CONTRAST MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BARIUM-BASED CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GADOLINIUM-BASED CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GADOLINIUM-BASED CONTRAST MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GADOLINIUM-BASED CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IODINATED CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IODINATED CONTRAST MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IODINATED CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MICROBUBBLE CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MICROBUBBLE CONTRAST MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MICROBUBBLE CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OPTICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPTICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL X-RAY & FLUOROSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL X-RAY & FLUOROSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL X-RAY & FLUOROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LIQUID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PASTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PASTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PASTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POWDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POWDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVASCULAR ROUTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVASCULAR ROUTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVASCULAR ROUTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ORAL ROUTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ORAL ROUTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ORAL ROUTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RECTAL ROUTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RECTAL ROUTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RECTAL ROUTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEPHROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEPHROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEPHROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GCC CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 135. GCC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 136. GCC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. GCC CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. G7 CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. G7 CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. G7 CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 156. G7 CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 157. G7 CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. G7 CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. NATO CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NATO CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 163. NATO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 164. NATO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. NATO CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. CANADA CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. CANADA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. CANADA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 177. CANADA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 178. CANADA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 179. CANADA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. CANADA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. MEXICO CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. MEXICO CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. MEXICO CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 184. MEXICO CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 185. MEXICO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 186. MEXICO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. MEXICO CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. BRAZIL CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. BRAZIL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. BRAZIL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 191. BRAZIL CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 192. BRAZIL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 193. BRAZIL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. BRAZIL CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. GERMANY CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. GERMANY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. GERMANY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 205. GERMANY CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 206. GERMANY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 207. GERMANY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. GERMANY CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. FRANCE CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. FRANCE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. FRANCE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 212. FRANCE CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 213. FRANCE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 214. FRANCE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. FRANCE CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. RUSSIA CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. RUSSIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. RUSSIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 219. RUSSIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 220. RUSSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 221. RUSSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. RUSSIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. ITALY CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. ITALY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. ITALY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 226. ITALY CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 227. ITALY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 228. ITALY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. ITALY CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. SPAIN CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. SPAIN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. SPAIN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 233. SPAIN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 234. SPAIN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 235. SPAIN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. SPAIN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. INDIA CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. INDIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. INDIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 247. INDIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 248. INDIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 249. INDIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. INDIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. JAPAN CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. JAPAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. JAPAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 254. JAPAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 255. JAPAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 256. JAPAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. JAPAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. AUSTRALIA CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 261. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 262. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 263. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 268. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 269. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 270. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)